India's Glenmark to Study Potential Covid-19 Drug Combination
The study will look to enroll 158 hospitalized patients of moderate COVID-19 in India, the company added.from Top India News- News18.com https://ift.tt/2A5aSsa
The study will look to enroll 158 hospitalized patients of moderate COVID-19 in India, the company added.
No comments